EGFR and melanoma: We subsequently used small molecular inhibitors of EGFR (gefitinib), IGF-1R (linsitinib), and CRAF (GW5074), as single agent or in combination to further verify whether these genes really participate in BRAFi resistance in VemR A375 melanoma cells.